🇺🇸 FDA
Patent

US 7993867

Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen

granted A61PA61P1/04

Quick answer

US patent 7993867 (Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen) held by The Regents of the University of California expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P1/04